Interpace Diagnostics Group's total assets for Q2 2025 were $12.34M, a decrease of -14.90% from the previous quarter. IDXG total liabilities were $13.55M for the fiscal quarter, a -10.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.